Njengoba incwadi ethi "I-Arthritis Cure" ithengiswe kuma-shopstores ezweni lonke ngo-1997, odokotela, abakhemisi kanye nabanesifo samathambo baye bavame ukubuzwa imibono yabo ye-glucosamine njengokwelashwa kwesifo samathambo . Igama elithi "ukwelapha" esihlokweni sencwadi lwakhulisa ithemba labaningi abahluphekayo nalesi sifo.
Indlela i-Glucosamine isebenza ngayo
I-glucosamine itholakala ekugxilweni okuphezulu emajoyini.
Kuye kwachazwa ukuthi i-glucosamine ivuselela ukwakhiwa kwe-cartilage ebalulekile ekulungiseni okuhlangene. Ezilwaneni zezilwane, umlomo we-glucosamine sulfate unomphumela omuhle ekuvukeni, isifo samathambo kanye nesifo samagciwane esithathelwanayo, nakuba singaphansi kakhulu kune-indomethacin nezinye izidakamizwa ezinjalo.
Ngezinye izikhathi i-glucosamine isetshenziswa ngokuhambisana ne-chondroitin sulfate njengokwelashwa kwesifo samathambo. I-Chondroitin sulfate itholakale enqoleni. Kubikwa ngokuthi i-Chondroitin sulfate igcina i-viscosity ezihlangene, ivuselela izindlela zokulungisa izidakamizwa, futhi ivimbela ama-enzyme ahlukumeza amanqamu.
Supplement Supplement
I-Glucosamine ithengiswa e-United States njengengxenye yokudla yokudla. I-Health Supplement Health and Education Act eyadluliselwa ngo-1994 yiCongress ivumela ukudayiswa komkhiqizo okuthiwa kuthinte isakhiwo noma umsebenzi womzimba ngokuthi "isondlo sokudla" ngaphandle kokuvunyelwa kwanoma iyiphi inhlangano kahulumeni.
Ukubhaliwe kufanele kufaka phakathi umshwalense wokuthi umkhiqizo awuzange uhlolwe yi-FDA futhi umkhiqizo awuhloselwe ukuxilonga, ukuphatha noma ukuvimbela noma yisiphi isifo. I-Glucosamine iyatholakala kuma-pharmacy nezitolo zokudla zezempilo njenge-sulfate, i-hydrochloride, i-n-acetyl, noma usawoti ukhilimu.
Izifundo zezokwelapha
Izifundo ezilawulwa isikhathi esifushane ziye zabika ukuthi i-glucosamine iyasebenza ekunciphiseni ubuhlungu iziguli ezine-osteoarthritis kanye nokwandisa ukuhamba kwazo .
Isivivinyo samaviki amane esiphambanweni sama-252 iziguli ezine-osteoarthritis emadolweni zathola ngomlomo glucosamine sulfate 500 mg. kathathu ngosuku kunempumelelo kakhulu kune-placebo ekunciphiseni izimpawu.
Esinye isilingo samasonto amabili esivivinyweni esiphambanisa iziguli ezingu-200 ezine-osteoarthritis emadolweni sibonisa ukuthi 500 mg. we-glucosamine sulfate njengempumelelo ekunciphiseni izimpawu njenge-ibuprofen 400 mg. kathathu ngosuku, emva kwesonto lesibili.
Esifundweni sesonto eliyisishiyagalombili esingaboni iziguli ezingu-40 ezine-osteoarthritis, i-glucosamine sulfate 500 mg. kathathu ngosuku ngomlomo kwakuphumelele njengoba ibuprofen 400 mg. kathathu ngosuku ekunciphiseni ubuhlungu ngemva kwamasonto amabili okuqala. Kuzo zonke imibiko i-glucosamine yayivame ukubekezelelana kahle nezimo zokucasuka kwamathumbu akuyona indawo ephakeme kune-placebo.
Lezi zifundo, nakuba ukuletha imiphumela efiselekayo kwakungacatshangwa ukuthi kuhlolwe kahle. Ucwaningo oluhlelwe kahle kufanele luqhutshwe besebenzisa izinombolo ezanele zeziguli ngaphezu kwesikhathi esanele, okungenani ngonyaka owodwa, ngabaphenyi abanolwazi, ngokusebenzisa izinyathelo zomgomo kanye namasu okubala ukuthi anganquma ukuthi ukuthuthukiswa kungumphumela oqondile wezokwelapha. Lezi zifundo zahlangana nezimbalwa ezimbalwa futhi zenziwa ngeziguli ezimbalwa kakhulu.
Ngokwenhlolovo ka-2004 yaseCanada, efaka iziguli ezingu-137, akukho mpela umehluko omkhulu phakathi kwephesenti yabahlanganyeli abavutha eqenjini le-placebo ngokumelene neqembu le-glucosamine.
Emhlanganweni we-ACR wonyaka ka-2005, kwavela imiphumela emibili yokuhlolwa kwe-glucosamine. I-GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial) yaxhaswa yi-NIH futhi yenzelwe ukunquma ukuphepha nokusebenza kahle nge-glucosamine, i-chondroitin, ethathwe ngokwehlukana noma ndawonye, kanye ne-GUIDE (i-Glucosamine Unum In Die Efficacy) kwakuyivivinyo lomtholampilo waseYurophu. Imiphumela ye-GUIDE ibonise i-glucosamine yanikeza usizo oluningi kune-acetaminophen.
Imiphumela ye-GAIT ikhombisa ukuthi inhlanganisela ye-glucosamine ne-chondroitin ingcono kune-placebo kodwa izinzuzo zibonakala zixhomeke ebukhulu bezinhlungu. Kuziguli ezinezinhlungu ezimhlophe ze-knee osteoarthritis , inhlanganisela ye-glucosamine chondroitin ayizange iphumelele kakhulu kune-placebo.
- Imiphumela ye-Glucosamine Trial Evezwe eMhlanganweni we-ACR ka-2005
- Ngabe I-Glucosamine Kufanele Yifake Kangakanani Umgudu Wokuthola Umphumela Owusizo?
Isiphetho
Ukuvumelana ukuthi i-glucosamine ne-supplement ye-chondroitin inganciphisa ubuhlungu kwezinye iziguli ezine- osteoarthritis. Odokotela abaningi manje bakholelwa ukuthi kudingekile ukuzama lezi zithako ze-osteoarthritis. Babonakala bephephile, kodwa odokotela baxwayisa iziguli ukuthi ikhwalithi nokusebenza kwe-glucosamine ne-chondroitin kuyahluka ngenxa yokungabi nomthetho. Uma ufuna ukuzama, thola imikhiqizo yekhwalithi ephakeme emthonjeni ohloniphekile.
Imithombo:
Incwadi Ethembisa Ukwelashwa, I-Arthritis Namuhla, Meyi-June 1997
Zama i-Glucosamine ye-OA, iArthritis Namuhla, ngoJulayi-Agasti 1998
I-Glucosamine ye-Arthritis, 1997 I-Medical Letter, Ikhasi lokuqala le-Quackwatch